Skip to main content
Journal cover image

The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes.

Publication ,  Journal Article
Worthington-Kirsch, R; Spies, JB; Myers, ER; Mulgund, J; Mauro, M; Pron, G; Peterson, ED; Goodwin, S; FIBROID Investigators,
Published in: Obstet Gynecol
July 2005

OBJECTIVE: To investigate the short-term safety of uterine embolization for leiomyomata in a large cohort of patients treated in a variety of clinical settings. METHODS: Examining the FIBROID Registry, a multicenter prospective voluntary registry of patients undergoing uterine embolization for leiomyomata, we studied the frequency of adverse events and predictors of adverse events within 30 days of the procedure. We also report on the technical aspects of the procedure, including details of periprocedural care, technique, and short-term recovery. All adverse events were recorded and classified using standard definitions, both in terms of type and severity. Summary statistics were used to describe the data set, and univariate and multivariate analyses were used to determine which factors might influence the incidence of adverse events. RESULTS: Of the 3,160 patients enrolled at 72 contributing sites, major in-hospital complications occurred in 0.66%, and postdischarge major events occurred in 4.8% within the first 30 days. The most common adverse event after discharge was inadequate pain relief requiring additional hospital treatment (2.4%). Thirty-one patients required additional surgical intervention within 30 days after treatment, 3 of whom required hysterectomy (0.1%). There were no deaths. Multivariate analysis showed modest increased odds for an adverse event for African Americans, smokers, and those with prior leiomyoma procedures. There were no differences in outcome based on the practice site experience, practice type, or any procedure-related factors. CONCLUSION: Uterine embolization for leiomyomata is a low-risk procedure with little variability in short-term outcome based on either patient demographics or practice setting. LEVEL OF EVIDENCE: II-3.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Obstet Gynecol

DOI

ISSN

0029-7844

Publication Date

July 2005

Volume

106

Issue

1

Start / End Page

52 / 59

Location

United States

Related Subject Headings

  • Uterine Neoplasms
  • Treatment Outcome
  • Time Factors
  • Severity of Illness Index
  • Risk Assessment
  • Registries
  • Prospective Studies
  • Probability
  • Obstetrics & Reproductive Medicine
  • Multicenter Studies as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Worthington-Kirsch, R., Spies, J. B., Myers, E. R., Mulgund, J., Mauro, M., Pron, G., … FIBROID Investigators, . (2005). The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol, 106(1), 52–59. https://doi.org/10.1097/01.AOG.0000165828.68787.a9
Worthington-Kirsch, Robert, James B. Spies, Evan R. Myers, Jyotsna Mulgund, Matthew Mauro, Gaylene Pron, Eric D. Peterson, Scott Goodwin, and Scott FIBROID Investigators. “The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes.Obstet Gynecol 106, no. 1 (July 2005): 52–59. https://doi.org/10.1097/01.AOG.0000165828.68787.a9.
Worthington-Kirsch R, Spies JB, Myers ER, Mulgund J, Mauro M, Pron G, et al. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. 2005 Jul;106(1):52–9.
Worthington-Kirsch, Robert, et al. “The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes.Obstet Gynecol, vol. 106, no. 1, July 2005, pp. 52–59. Pubmed, doi:10.1097/01.AOG.0000165828.68787.a9.
Worthington-Kirsch R, Spies JB, Myers ER, Mulgund J, Mauro M, Pron G, Peterson ED, Goodwin S, FIBROID Investigators. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. 2005 Jul;106(1):52–59.
Journal cover image

Published In

Obstet Gynecol

DOI

ISSN

0029-7844

Publication Date

July 2005

Volume

106

Issue

1

Start / End Page

52 / 59

Location

United States

Related Subject Headings

  • Uterine Neoplasms
  • Treatment Outcome
  • Time Factors
  • Severity of Illness Index
  • Risk Assessment
  • Registries
  • Prospective Studies
  • Probability
  • Obstetrics & Reproductive Medicine
  • Multicenter Studies as Topic